EUVIMEDEUVIMED entdecken
Crossref

CB839-assisted preferential infection and replication of oncolytic adenovirus for enhanced oncolytic virotherapy

Weiyue Ban, Shihua Yang, Zhichao Chen, Hai Jiang, Yuyao Huang, Zhenguo Cheng, Zhonggui He, Mengchi Sun, Jin Sun

Chinese Chemical Letters · 2026-05 · 113013

DOI: 10.1016/j.cclet.2026.113013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-05. Verfasst von Weiyue Ban und 8 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Liaoning Revitalization Talents Program, Shenyang Pharmaceutical University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China
  • Liaoning Revitalization Talents Program
  • Shenyang Pharmaceutical University
  • National Key Research and Development Program of China

Zitieren

APA

Ban, W., Yang, S., Chen, Z., Jiang, H., Huang, Y., Cheng, Z., He, Z., Sun, M., & Sun, J. (2026). CB839-assisted preferential infection and replication of oncolytic adenovirus for enhanced oncolytic virotherapy. Chinese Chemical Letters, 113013. https://doi.org/10.1016/j.cclet.2026.113013

Vancouver

Ban W, Yang S, Chen Z, Jiang H, Huang Y, Cheng Z, et al. CB839-assisted preferential infection and replication of oncolytic adenovirus for enhanced oncolytic virotherapy. Chinese Chemical Letters. 2026:113013. doi:10.1016/j.cclet.2026.113013

BibTeX
@article{Ban2026,
  author = {Ban, Weiyue and Yang, Shihua and Chen, Zhichao and Jiang, Hai and Huang, Yuyao and Cheng, Zhenguo and He, Zhonggui and Sun, Mengchi and Sun, Jin},
  title = {CB839-assisted preferential infection and replication of oncolytic adenovirus for enhanced oncolytic virotherapy},
  journal = {Chinese Chemical Letters},
  year = {2026},
  pages = {113013},
  doi = {10.1016/j.cclet.2026.113013}
}
Kostenlos starten →